Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Clinical Utility of Rush Venom Immunotherapy: Current Status.

Gruzelle V, Mailhol C, Waters DW, Guilleminault L.

J Asthma Allergy. 2020 Jan 7;13:1-10. doi: 10.2147/JAA.S200917. eCollection 2020. Review.

2.

Overweight and bronchospasm during general anaesthesia: An association with heterogeneous mechanisms.

Dardé X, Mailhol C, Migueres I, Didier A, Guilleminault L.

Allergol Int. 2020 Jan 17. pii: S1323-8930(20)30007-1. doi: 10.1016/j.alit.2019.12.012. [Epub ahead of print] No abstract available.

3.

[Asthma and obesity in adults].

Villeneuve T, Guilleminault L.

Rev Mal Respir. 2020 Jan;37(1):60-74. doi: 10.1016/j.rmr.2019.03.016. Epub 2019 Dec 19. Review. French.

PMID:
31866123
4.

Management of pulmonary toxicity associated with immune checkpoint inhibitors.

Delaunay M, Prévot G, Collot S, Guilleminault L, Didier A, Mazières J.

Eur Respir Rev. 2019 Nov 6;28(154). pii: 190012. doi: 10.1183/16000617.0012-2019. Print 2019 Dec 31. Review.

5.

Exhaled nitric oxide in chronic cough: A good tool in a multi-step approach.

Lamon T, Didier A, Brouquières D, Escamilla R, Dupuis M, Guibert N, Leseux L, Guilleminault L.

Respir Med Res. 2019 Nov;76:4-9. doi: 10.1016/j.resmer.2019.04.005. Epub 2019 Apr 20.

PMID:
31254946
6.

New understanding in the treatment of cough (NEUROCOUGH) ERS Clinical Research Collaboration: improving care and treatment for patients with cough.

McGarvey L, Dupont L, Birring SS, Boyd J, Chung KF, Dabrowska M, Domingo C, Fontana G, Guilleminault L, Kardos P, Millqvist E, Morice AH, Smith JA, van den Berg JW, Van de Kerkhove C; NEUROCOUGH Clinical Research Collaboration.

Eur Respir J. 2019 May 30;53(5). pii: 1900787. doi: 10.1183/13993003.00787-2019. Print 2019 May. No abstract available.

PMID:
31147424
7.

[From acute cough to chronic cough in adults: Overview on a common reason for consultation].

Guilleminault L, Brouquières D, Didier A.

Presse Med. 2019 Apr;48(4):353-364. doi: 10.1016/j.lpm.2019.02.009. Epub 2019 Mar 27. Review. French.

PMID:
30926203
8.

[Severe asthma revisited by biologic therapies emergences].

Guilleminault L, Didier A.

Presse Med. 2019 Mar;48(3 Pt 1):310-321. doi: 10.1016/j.lpm.2019.03.001. Epub 2019 Mar 26. Review. French.

PMID:
30922670
9.

[Management of chronic cough in France: A survey of clinical practice].

Guilleminault L, Brouquières D, Messekher M, Dalphin JC, Didier A, Escamilla R.

Rev Mal Respir. 2019 Mar;36(3):372-376. doi: 10.1016/j.rmr.2018.12.002. Epub 2019 Mar 18. French. No abstract available.

PMID:
30898467
10.

Chronic cough and obesity.

Guilleminault L.

Pulm Pharmacol Ther. 2019 Apr;55:84-88. doi: 10.1016/j.pupt.2019.01.009. Epub 2019 Feb 25. Review.

PMID:
30817992
11.

Serum IgG Concentrations in Adult Patients Experiencing Virus-Induced Severe Asthma Exacerbations.

Verduyn M, Botto G, Jaubert J, Lier C, Flament T, Guilleminault L.

J Allergy Clin Immunol Pract. 2019 May - Jun;7(5):1507-1513.e1. doi: 10.1016/j.jaip.2018.12.028. Epub 2019 Jan 14.

12.

Safety of ultra-rush protocols for hymenoptera venom immunotherapy in systemic mastocytosis.

Gruzelle V, Ramassamy M, Bulai Lidiveanu C, Didier A, Mailhol C, Guilleminault L.

Allergy. 2018 Nov;73(11):2260-2263. doi: 10.1111/all.13557. Epub 2018 Jul 26. No abstract available.

PMID:
29984458
13.

[Characteristics of non-pharmacological interventions in the elderly with COPD. Smoking cessation, pulmonary rehabilitation, nutritional management and patient education].

Guilleminault L, Rolland Y, Didier A.

Rev Mal Respir. 2018 Jun;35(6):626-641. doi: 10.1016/j.rmr.2017.12.004. Epub 2018 Jun 22. Review. French.

PMID:
29937313
14.

Therapeutic antibodies: A new era in the treatment of respiratory diseases?

Sécher T, Guilleminault L, Reckamp K, Amanam I, Plantier L, Heuzé-Vourc'h N.

Pharmacol Ther. 2018 Sep;189:149-172. doi: 10.1016/j.pharmthera.2018.05.003. Epub 2018 May 4. Review.

PMID:
29730443
15.

Diet and Asthma: Is It Time to Adapt Our Message?

Guilleminault L, Williams EJ, Scott HA, Berthon BS, Jensen M, Wood LG.

Nutrients. 2017 Nov 8;9(11). pii: E1227. doi: 10.3390/nu9111227. Review.

16.

Lung function parameters in omalizumab responder patients: An interesting tool?

Paganin F, Mangiapan G, Proust A, Prudhomme A, Attia J, Marchand-Adam S, Pellet F, Milhe F, Melloni B, Bernady A, Raspaud C, Nocent C, Berger P, Guilleminault L.

Allergy. 2017 Dec;72(12):1953-1961. doi: 10.1111/all.13202. Epub 2017 Jun 14.

PMID:
28517027
17.

[Blomia tropicalis: A house dust mite in the tropics].

Guilleminault L, Viala-Gastan C.

Rev Mal Respir. 2017 Oct;34(8):791-801. doi: 10.1016/j.rmr.2016.10.877. Epub 2017 May 12. Review. French.

PMID:
28502519
18.

Personalised medicine in asthma: from curative to preventive medicine.

Guilleminault L, Ouksel H, Belleguic C, Le Guen Y, Germaud P, Desfleurs E, Leroyer C, Magnan A.

Eur Respir Rev. 2017 Jan 3;26(143). pii: 160010. doi: 10.1183/16000617.0010-2016. Print 2017 Jan. Review.

19.

Asthma and Hypogammaglobulinemia: an Asthma Phenotype with Low Type 2 Inflammation.

Dupin C, Marchand-Adam S, Favelle O, Costes R, Gatault P, Diot P, Grammatico-Guillon L, Guilleminault L.

J Clin Immunol. 2016 Nov;36(8):810-817. Epub 2016 Oct 6.

PMID:
27714565
20.

Development of a drug delivery system for efficient alveolar delivery of a neutralizing monoclonal antibody to treat pulmonary intoxication to ricin.

Respaud R, Marchand D, Pelat T, Tchou-Wong KM, Roy CJ, Parent C, Cabrera M, Guillemain J, Mac Loughlin R, Levacher E, Fontayne A, Douziech-Eyrolles L, Junqua-Moullet A, Guilleminault L, Thullier P, Guillot-Combe E, Vecellio L, Heuzé-Vourc'h N.

J Control Release. 2016 Jul 28;234:21-32. doi: 10.1016/j.jconrel.2016.05.018. Epub 2016 May 9.

PMID:
27173943
21.

Pulmonary arterial hypertension in adult onset Still's disease: a case report of a severe complication.

Guilleminault L, Laurent S, Foucher A, Poubeau P, Paganin F.

BMC Pulm Med. 2016 May 10;16(1):72. doi: 10.1186/s12890-016-0237-x.

22.

[Seasonality in asthma: Impact and treatments].

Guilleminault L, Just J, Humbert M, Leroyer C, Epaud R.

Presse Med. 2016 Nov;45(11):1005-1018. doi: 10.1016/j.lpm.2016.01.019. Epub 2016 Mar 30. Review. French.

PMID:
27039335
23.

What are the characteristics of asthma patients with elevated serum IgG4 levels?

Flament T, Marchand-Adam S, Gatault P, Dupin C, Diot P, Guilleminault L.

Respir Med. 2016 Mar;112:39-44. doi: 10.1016/j.rmed.2016.01.014. Epub 2016 Jan 22.

24.

A large and unusual lung abscess with positive culture to Slackia exigua.

Roingeard C, Jaubert J, Guilleminault L.

Int J Infect Dis. 2015 Nov;40:37-8. doi: 10.1016/j.ijid.2015.09.015. Epub 2015 Sep 30. No abstract available.

25.

Emergence of community-acquired Clostridium difficile infection: the experience of a French hospital and review of the literature.

Ogielska M, Lanotte P, Le Brun C, Valentin AS, Garot D, Tellier AC, Halimi JM, Colombat P, Guilleminault L, Lioger B, Vegas H, De Toffol B, Constans T, Bernard L.

Int J Infect Dis. 2015 Aug;37:36-41. doi: 10.1016/j.ijid.2015.06.007. Epub 2015 Jun 17. Review.

26.

Pharmacokinetics of Colistin Methansulphonate (CMS) and Colistin after CMS Nebulisation in Baboon Monkeys.

Marchand S, Bouchene S, de Monte M, Guilleminault L, Montharu J, Cabrera M, Grégoire N, Gobin P, Diot P, Couet W, Vecellio L.

Pharm Res. 2015 Oct;32(10):3403-14. doi: 10.1007/s11095-015-1716-0. Epub 2015 Jun 4.

PMID:
26040660
27.

A good night for a bad day.

Guilleminault L, Sigmann MH, Paganin F.

Thorax. 2015 Jun;70(6):604, 607. doi: 10.1136/thoraxjnl-2015-206955. Epub 2015 Apr 9. No abstract available.

PMID:
25858908
28.

[Immunotherapy in non-small cell lung cancer: inhibition of PD1/PDL1 pathway].

Guilleminault L, Carmier D, Heuzé-Vourc'h N, Diot P, Pichon E.

Rev Pneumol Clin. 2015 Feb;71(1):44-56. doi: 10.1016/j.pneumo.2014.11.004. Epub 2015 Feb 14. Review. French.

PMID:
25687821
29.

Gastroesophageal reflux disease is a risk factor for severity of organizing pneumonia.

Gaillet G, Favelle O, Guilleminault L, de Muret A, Lemarie E, Lecomte T, Marchand-Adam S, Diot P.

Respiration. 2015;89(2):119-26. doi: 10.1159/000369470. Epub 2015 Jan 28.

30.

VEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras activating-mutations.

Hervé V, Rabbe N, Guilleminault L, Paul F, Schlick L, Azzopardi N, Duruisseaux M, Fouquenet D, Montharu J, Redini F, Paintaud G, Lemarié E, Cadranel J, Wislez M, Heuzé-Vourc'h N.

MAbs. 2014;6(6):1638-48. doi: 10.4161/mabs.34454.

31.

Fate of inhaled monoclonal antibodies after the deposition of aerosolized particles in the respiratory system.

Guilleminault L, Azzopardi N, Arnoult C, Sobilo J, Hervé V, Montharu J, Guillon A, Andres C, Herault O, Le Pape A, Diot P, Lemarié E, Paintaud G, Gouilleux-Gruart V, Heuzé-Vourc'h N.

J Control Release. 2014 Dec 28;196:344-54. doi: 10.1016/j.jconrel.2014.10.003. Epub 2014 Oct 17.

PMID:
25451545
32.

[Interstitial lung disease in connective tissue disorders].

Carmier D, Diot É, Guilleminault L, Marchand-Adam S.

Rev Prat. 2014 Sep;64(7):941-5. Review. French.

PMID:
25362775
33.

Noninvasive diagnosis of actionable mutations by deep sequencing of circulating free DNA in lung cancer from never-smokers: a proof-of-concept study from BioCAST/IFCT-1002.

Couraud S, Vaca-Paniagua F, Villar S, Oliver J, Schuster T, Blanché H, Girard N, Trédaniel J, Guilleminault L, Gervais R, Prim N, Vincent M, Margery J, Larivé S, Foucher P, Duvert B, Vallee M, Le Calvez-Kelm F, McKay J, Missy P, Morin F, Zalcman G, Olivier M, Souquet PJ; BioCAST/IFCT-1002 investigators.

Clin Cancer Res. 2014 Sep 1;20(17):4613-24. doi: 10.1158/1078-0432.CCR-13-3063. Epub 2014 Jul 10.

34.

An evaluation of a new single-use flexible bronchoscope with a large suction channel: reliability of bronchoalveolar lavage in ventilated piglets and initial clinical experience.

Mankikian J, Ehrmann S, Guilleminault L, Le Fol T, Barc C, Ferrandière M, Boulain T, Dequin PF, Guillon A.

Anaesthesia. 2014 Jul;69(7):701-6. doi: 10.1111/anae.12641. Epub 2014 Apr 28.

35.

Initial characteristics and outcome of hospitalized patients with amiodarone pulmonary toxicity.

Mankikian J, Favelle O, Guillon A, Guilleminault L, Cormier B, Jonville-Béra AP, Perrotin D, Diot P, Marchand-Adam S.

Respir Med. 2014 Apr;108(4):638-46. doi: 10.1016/j.rmed.2014.01.014. Epub 2014 Feb 10.

36.

Diffuse panbronchiolitis and IgA nephropathy.

Tossier C, Pilette C, Guilleminault L, Buchler M, de Muret A, Diot P, Adam SM.

Am J Respir Crit Care Med. 2014 Jan 1;189(1):106-9. doi: 10.1164/rccm.201307-1381LE. No abstract available.

PMID:
24381993
37.

Can exhaled nitric oxide differentiate causes of pulmonary fibrosis?

Guilleminault L, Saint-Hilaire A, Favelle O, Caille A, Boissinot E, Henriet AC, Diot P, Marchand-Adam S.

Respir Med. 2013 Nov;107(11):1789-96. doi: 10.1016/j.rmed.2013.07.007. Epub 2013 Sep 5.

38.

Asthma unmasked with tumor necrosis factor-α-blocking drugs.

Guilleminault L, Carré P, Beau-Salinas F, Taillé C, Dieudé P, Crestani B, Diot P, Marchand-Adam S.

Chest. 2011 Oct;140(4):1068-1071. doi: 10.1378/chest.10-2350.

PMID:
21972387
39.

The airways, a novel route for delivering monoclonal antibodies to treat lung tumors.

Maillet A, Guilleminault L, Lemarié E, Lerondel S, Azzopardi N, Montharu J, Congy-Jolivet N, Reverdiau P, Legrain B, Parent C, Douvin DH, Hureaux J, Courty Y, De Monte M, Diot P, Paintaud G, Le Pape A, Watier H, Heuzé-Vourc'h N.

Pharm Res. 2011 Sep;28(9):2147-56. doi: 10.1007/s11095-011-0442-5. Epub 2011 Apr 14.

PMID:
21491145
40.

[Tropical pneumonia: pulmonary melioidosis].

Guilleminault L, Holstein A, Azzouz M, Favelle O, Lanotte P, Diot P.

Rev Med Interne. 2010 Jul;31(7):e4-7. doi: 10.1016/j.revmed.2009.07.019. Epub 2010 Apr 21. French.

PMID:
20413195
41.

Hypersensitivity pneumonitis associated with temozolomide.

Guilleminault L, Carré P, Diot P.

Eur Respir J. 2009 Aug;34(2):526. doi: 10.1183/09031936.00065909. No abstract available.

42.

[Lung abscess secondary to neutropenic myelodysplasia treated with G-CSF].

Guilleminault L, Espanel C, Marcq M, Azzouz M, Diot E, Binet C, Diot P.

Rev Mal Respir. 2009 Jan;26(1):87-9. French. No abstract available.

PMID:
19212297
43.

[Alveolo-interstitial pneumonia due to Temozolamide].

Guilleminault L, Carré P, de Luca K, Beau Salinas F, Autret-Leca E, Narciso B, Diot P.

Rev Mal Respir. 2008 Sep;25(7):880-4. French.

PMID:
18946417

Supplemental Content

Loading ...
Support Center